Retrospective Review Clinical Use of a cfDNA Blood Test for Identification of Targetable Molecular Alterations in Patients with Lung Cancer

被引:2
作者
Tran, Hai [1 ]
Zhang, Jianjun [1 ]
Vasquez, Marya [1 ]
Fossella, Frank [1 ]
Simon, George [1 ]
Tsao, Anne [1 ]
Gibbons, Don Lynn [1 ]
Elamin, Yasir [1 ]
Banks, Kimberly [2 ]
Lanman, Richard [2 ]
Papadimitrakopoulou, Vassiliki [1 ]
Heymach, John [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Thorac & Head & Neck Med Oncol, Houston, TX 77030 USA
[2] Guardant Hlth Inc, Redwood City, CA USA
关键词
lung cancer; cfDNA; ctDNA; molecular alterations;
D O I
10.1016/j.jtho.2016.11.1311
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P2.03b-030
引用
收藏
页码:S952 / S952
页数:1
相关论文
共 50 条
  • [41] Retrospective Cohort Study of Clinical Efficacy and Safety of Cefozopran for Treating Febrile Neutropenia during Chemotherapy in Patients with Lung Cancer
    Higashionnaa, Tsukasa
    Ushio, Soichiro
    Esumi, Satoru
    Murakawaa, Kiminaka
    Kitamura, Yoshihisa
    Sendo, Toshiaki
    ACTA MEDICA OKAYAMA, 2022, 76 (02) : 167 - 172
  • [42] Impact of Coronavirus Disease 2019 on Clinical Characteristics in Patients With Lung Cancer: A Large Single-Centre Retrospective Study
    Zhang, Yu
    Li, Jie
    Li, Zhi-Ke
    Yang, Xiyue
    Bai, Jie
    Liu, Lihua
    Dai, Tangzhi
    Feng, Gang
    Li, Qiu
    Du, Xiaobo
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [43] Prevalence and clinical characteristics of venous thromboembolism in patients with lung cancer: a systematic review and meta-analysis
    Xu, Ying
    Wu, Tong
    Ren, Xue
    Liu, Jing
    Zhang, Haibo
    Yang, Defu
    Yan, Ying
    Lv, Dongyang
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [44] Increased sympathetic nervous system impairs prognosis in lung cancer patients: a scoping review of clinical studies
    Garramona, Fabricio T.
    Cunha, Telma F.
    Vieira, Janaina S.
    Borges, Gabriela
    Santos, Gabriela
    de Castro, Gilberto
    Ugrinowitsch, Carlos
    Brum, Patricia C.
    LUNG CANCER MANAGEMENT, 2023, 12 (04)
  • [45] Clinical manifestation and outcome of lung cancer patients with ocular metastasis: 16 case reports and systematic review
    Liu, Yunxin
    Feng, Xiaoyi
    Xu, Yan
    Yu, Siyuan
    Wang, Mengzhao
    THORACIC CANCER, 2024, 15 (30) : 2147 - 2155
  • [46] Serial cfDNA assessment of response and resistance to EGFR-TKI for patients with EGFR-L858R mutant lung cancer from a prospective clinical trial
    Zhou, Qing
    Yang, Jin-Ji
    Chen, Zhi-Hong
    Zhang, Xu-Chao
    Yan, Hong-Hong
    Xu, Chong-Rui
    Su, Jian
    Chen, Hua-Jun
    Tu, Hai-Yan
    Zhong, Wen-Zhao
    Yang, Xue-Ning
    Wu, Yi-Long
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 9
  • [47] Serial cfDNA assessment of response and resistance to EGFR-TKI for patients with EGFR-L858R mutant lung cancer from a prospective clinical trial
    Qing Zhou
    Jin-Ji Yang
    Zhi-Hong Chen
    Xu-Chao Zhang
    Hong-Hong Yan
    Chong-Rui Xu
    Jian Su
    Hua-Jun Chen
    Hai-Yan Tu
    Wen-Zhao Zhong
    Xue-Ning Yang
    Yi-Long Wu
    Journal of Hematology & Oncology, 9
  • [48] Lung cancer screening in clinical practice: identification of high-risk chronic obstructive pulmonary disease patients
    Sousa, Sofia Rodrigues
    Caldeira, Joao Nunes
    Rodrigues, Cidalia
    Figueiredo, Ana
    Barata, Fernando
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2022, 68 (04): : 502 - 506
  • [49] The long tail of molecular alterations in non-small cell lung cancer: a single-institution experience of next-generation sequencing in clinical molecular diagnostics
    Fumagalli, Caterina
    Vacirca, Davide
    Rappa, Alessandra
    Passaro, Antonio
    Guarize, Juliana
    Raviele, Paola Rafaniello
    de Marinis, Filippo
    Spaggiari, Lorenzo
    Casadio, Chiara
    Viale, Giuseppe
    Barberis, Massimo
    Guerini-Rocco, Elena
    JOURNAL OF CLINICAL PATHOLOGY, 2018, 71 (09) : 767 - 773
  • [50] The clinical, molecular, and therapeutic implications of time from primary diagnosis to brain metastasis in lung and breast cancer patients
    Ge, Haitao
    Zhu, Kaibin
    Sun, Qian
    Wang, Huan
    Liu, Hui
    Ge, Jinyi
    Liu, Chunyang
    Liang, Peng
    Lv, Zhonghua
    Bao, Hongbo
    CANCER MEDICINE, 2024, 13 (11):